Literature DB >> 32232914

Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure.

Massimo Pozzoli1, Jose Gonzalez-Costello2, Antoni Bayes-Genis3, Gianfranco Sinagra4, Stefan D Anker5,6,7, Andrew J S Coats8, Marisa G Crespo-Leiro9, Gerasimos Filippatos10, Cécile Laroche11, Aldo P Maggioni11,12, Alexandre Mebazaa13,14,15, Massimo F Piepoli16, Luigi Tavazzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32232914     DOI： 10.1002/ejhf.1789

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  3 in total

1.  Anticoagulation versus placebo for heart failure in sinus rhythm.

Authors:  Eduard Shantsila; Monika Kozieł; Gregory Yh Lip
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

2.  Clinical Characteristics of Venous Thrombosis Associated with Peripherally Inserted Central Venous Catheter in Premature Infants.

Authors:  Weiwei Zhu; Hua Zhang; Yan Xing
Journal:  Children (Basel)       Date:  2022-07-28

3.  Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry.

Authors:  Gilles Lemesle; Sandro Ninni; Pascal de Groote; Guillaume Schurtz; Nicolas Lamblin; Christophe Bauters
Journal:  ESC Heart Fail       Date:  2020-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.